The potential for biosimilars to address unmet clinical need - Is the developed world missing out?
作者信息
Yeoh Whei Chuern, Situnayake Deva, Moots Robert J
机构信息
Department of Rheumatology, Liverpool University Hospital NHS Foundation Trust, Liverpool, United Kingdom.
Department of Rheumatology, Sandwell and West Birmingham Hospitals, Birmingham United Kingdom.
出版信息
Rheumatol Immunol Res. 2025 Jan 9;5(4):186-188. doi: 10.1515/rir-2024-0027. eCollection 2024 Dec.
Abstract
摘要
相似文献
1
The potential for biosimilars to address unmet clinical need - Is the developed world missing out?生物类似药满足未被满足的临床需求的潜力——发达国家是否错失良机？
Rheumatol Immunol Res. 2025 Jan 9;5(4):186-188. doi: 10.1515/rir-2024-0027. eCollection 2024 Dec.
2
Patient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of Experts.患者可及性、未满足的医疗需求、预期获益以及对东欧国家生物类似药使用的关注：专家调查。
Biomed Res Int. 2018 Jan 10;2018:9597362. doi: 10.1155/2018/9597362. eCollection 2018.
3
Reviewing the evidence for biosimilars: key insights, lessons learned and future horizons.审视生物类似药的证据：关键见解、经验教训与未来展望。
Rheumatology (Oxford). 2017 Aug 1;56(suppl_4):iv49-iv62. doi: 10.1093/rheumatology/kex276.
4
The economics of biosimilars and challenges to biosimilar adoption in low- and middle-income countries.生物类似药的经济学以及低收入和中等收入国家在采用生物类似药方面面临的挑战。
Expert Opin Biol Ther. 2023 Jul-Dec;23(8):653-657. doi: 10.1080/14712598.2023.2247972. Epub 2023 Aug 18.
5
Consensus-Based Overarching Principles and Recommendations on the Use of Biosimilars in the Treatment of Inflammatory Arthritis in the Gulf Region.《海湾地区炎症性关节炎生物类似药治疗应用的共识性总体原则和推荐意见》。
BioDrugs. 2024 May;38(3):449-463. doi: 10.1007/s40259-023-00642-1. Epub 2024 Feb 25.
6
Biosimilars-Emerging Role in Nephrology.生物类似药——在肾脏病学中的新兴作用。
Clin J Am Soc Nephrol. 2019 Sep 6;14(9):1391-1398. doi: 10.2215/CJN.01980218. Epub 2018 Aug 6.
7
Progress in oncology biosimilars till 2020: Scrutinizing comparative studies of biosimilar monoclonal antibodies.2020 年肿瘤生物类似药的进展：生物类似性单克隆抗体比较研究的审查。
J Oncol Pharm Pract. 2021 Jul;27(5):1195-1204. doi: 10.1177/10781552211016083. Epub 2021 Jun 6.
8
[The Polish Task Force position statement on safety of biologic treatment with monoclonal antibodies and soluble receptors].[波兰特别工作组关于单克隆抗体和可溶性受体生物治疗安全性的立场声明]
Pol Merkur Lekarski. 2014 Jul;37(217):5-9.
9
Rituximab biosimilars in hematologic malignancies: the need for a real-world approach.血液系统恶性肿瘤中的利妥昔单抗生物类似药：需要真实世界的方法。
Future Oncol. 2020 Sep;16(26):2017-2027. doi: 10.2217/fon-2020-0131. Epub 2020 Jun 29.
10
The European Perspective and History on Biosimilars for the Treatment of Inflammatory Bowel Diseases.欧洲关于用于治疗炎症性肠病的生物类似药的观点与历史
Crohns Colitis 360. 2021 Feb 23;3(1):otab012. doi: 10.1093/crocol/otab012. eCollection 2021 Jan.
本文引用的文献
1
Infliximab vs interferon-α in the treatment of Behçet's syndrome: clinical data from the BIO-BEHÇET'S randomized controlled trial.英夫利昔单抗与干扰素-α治疗白塞病的疗效比较：来自BIO-BEHÇET随机对照试验的临床数据
Rheumatology (Oxford). 2025 May 1;64(5):2882-2891. doi: 10.1093/rheumatology/keae585.
2
The cost savings of biosimilars can help increase patient access and lift the financial burden of health care systems.生物类似药的成本节约有助于增加患者的可及性，并减轻医疗保健系统的财务负担。
Semin Arthritis Rheum. 2022 Feb;52:151939. doi: 10.1016/j.semarthrit.2021.11.009. Epub 2021 Dec 30.
3
Clinical and Regulatory Concerns of Biosimilars: A Review of Literature.生物类似药的临床和监管关注：文献综述。
Int J Environ Res Public Health. 2020 Aug 11;17(16):5800. doi: 10.3390/ijerph17165800.
4
Era of biosimilars in rheumatology: reshaping the healthcare environment.生物类似药时代：重塑医疗保健环境。
RMD Open. 2019 May 21;5(1):e000900. doi: 10.1136/rmdopen-2019-000900. eCollection 2019.
5
Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17.聚乙二醇干扰素-α-2b 通过上调循环调节性 T 细胞和减少 Th17 来降低 Behçet 病患者的皮质类固醇需求。
Ann Rheum Dis. 2015 Jun;74(6):1138-44. doi: 10.1136/annrheumdis-2014-205571. Epub 2014 Sep 30.
6
Biosimilar therapeutics-what do we need to consider?生物类似药疗法——我们需要考虑什么？
NDT Plus. 2009 Jan;2(Suppl_1):i27-i36. doi: 10.1093/ndtplus/sfn177.
Zotero 插件